Nicholson John 4
4 · NEKTAR THERAPEUTICS · Filed Jan 30, 2019
Insider Transaction Report
Form 4
Nicholson John
SVP & Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2019-01-28$10.69/sh+63,000$673,470→ 237,477 total - Sale
Common Stock
2019-01-28$42.82/sh−63,000$2,697,660→ 174,477 total - Exercise/Conversion
Stock Option
2019-01-28$10.69/sh−63,000$673,470→ 0 totalExercise: $10.69From: 2015-02-08Exp: 2019-02-07→ Common Stock (63,000 underlying)
Footnotes (2)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Nicholson for certain options expiring on February 7, 2019.
- [F2]This transaction was executed in multiple trades at prices ranging from $42.31 to $43.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.